Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus

Robert W Arnold Alaska Blind Child Discovery, Alaska Children’s Eye and Strabismus, Anchorage, AK, USACorrespondence: Robert W ArnoldAlaska Blind Child Discovery, Alaska Children’s Eye and Strabismus, 3500 Latouche #280, Anchorage, AK 99508, USATel +1 907 561-1917Fax +1 907 563-5...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Arnold RW
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/3f2e5ce4ff2140289768dc43f2a61848
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3f2e5ce4ff2140289768dc43f2a61848
record_format dspace
spelling oai:doaj.org-article:3f2e5ce4ff2140289768dc43f2a618482021-12-02T11:18:39ZComparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus1177-5483https://doaj.org/article/3f2e5ce4ff2140289768dc43f2a618482020-01-01T00:00:00Zhttps://www.dovepress.com/comparative-aapos-validation-of-the-birefringent-amblyopia-screener-wi-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Robert W Arnold Alaska Blind Child Discovery, Alaska Children’s Eye and Strabismus, Anchorage, AK, USACorrespondence: Robert W ArnoldAlaska Blind Child Discovery, Alaska Children’s Eye and Strabismus, 3500 Latouche #280, Anchorage, AK 99508, USATel +1 907 561-1917Fax +1 907 563-5373Email eyedoc@alaska.netBackground: The Rebion blinq binocular birefringent ocular alignment screener was recently commercially released, but it did not yet have validation by American Association for Pediatric Ophthalmology and Strabismus (AAPOS) uniform guidelines.Methods: Children and adults from a high-risk eye practice had screening by blinq with validation by AAPOS 2003 guidelines. Then, the blinq was compared to the Adaptica 2WIN with CR corneal reflex strabismus estimation by AAPOS 2003 guidelines plus additional efforts to identify patients with diminished binocularity.Results: Blinq in 100 patients compared to 2003 AAPOS amblyopia risk factors (ARF) had sensitivity 67%, specificity 75% and PPV of 82%. Both blinq and 2WIN were completed by 87 patients median age 6.5 years. Sensitivity, specificity and positive predictive value (PPV) for blinq were 75%, 68% and 81% whereas 2WIN had 91%, 68% and 84%. The blinq referred two young patients with isolated, small-angle strabismic amblyopia that 2WIN refractive function passed.Conclusion: Despite its non-refractive design to identify binocular foveation, blinq performed well with refractive and strabismic uniform risk factors and a PPV greater than 80%.Clinical Trials Registry: NCT04195711.Keywords: birefringent, photoscreening, amblyopia, fixation instability, amblyopia risk factor, strabismusArnold RWDove Medical Pressarticlebirefringentphotoscreeningamblyopiafixation instabilityamblyopia risk factorstrabismusOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 325-329 (2020)
institution DOAJ
collection DOAJ
language EN
topic birefringent
photoscreening
amblyopia
fixation instability
amblyopia risk factor
strabismus
Ophthalmology
RE1-994
spellingShingle birefringent
photoscreening
amblyopia
fixation instability
amblyopia risk factor
strabismus
Ophthalmology
RE1-994
Arnold RW
Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus
description Robert W Arnold Alaska Blind Child Discovery, Alaska Children’s Eye and Strabismus, Anchorage, AK, USACorrespondence: Robert W ArnoldAlaska Blind Child Discovery, Alaska Children’s Eye and Strabismus, 3500 Latouche #280, Anchorage, AK 99508, USATel +1 907 561-1917Fax +1 907 563-5373Email eyedoc@alaska.netBackground: The Rebion blinq binocular birefringent ocular alignment screener was recently commercially released, but it did not yet have validation by American Association for Pediatric Ophthalmology and Strabismus (AAPOS) uniform guidelines.Methods: Children and adults from a high-risk eye practice had screening by blinq with validation by AAPOS 2003 guidelines. Then, the blinq was compared to the Adaptica 2WIN with CR corneal reflex strabismus estimation by AAPOS 2003 guidelines plus additional efforts to identify patients with diminished binocularity.Results: Blinq in 100 patients compared to 2003 AAPOS amblyopia risk factors (ARF) had sensitivity 67%, specificity 75% and PPV of 82%. Both blinq and 2WIN were completed by 87 patients median age 6.5 years. Sensitivity, specificity and positive predictive value (PPV) for blinq were 75%, 68% and 81% whereas 2WIN had 91%, 68% and 84%. The blinq referred two young patients with isolated, small-angle strabismic amblyopia that 2WIN refractive function passed.Conclusion: Despite its non-refractive design to identify binocular foveation, blinq performed well with refractive and strabismic uniform risk factors and a PPV greater than 80%.Clinical Trials Registry: NCT04195711.Keywords: birefringent, photoscreening, amblyopia, fixation instability, amblyopia risk factor, strabismus
format article
author Arnold RW
author_facet Arnold RW
author_sort Arnold RW
title Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus
title_short Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus
title_full Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus
title_fullStr Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus
title_full_unstemmed Comparative AAPOS Validation of the Birefringent Amblyopia Screener with Isolated Small-Angle Strabismus
title_sort comparative aapos validation of the birefringent amblyopia screener with isolated small-angle strabismus
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/3f2e5ce4ff2140289768dc43f2a61848
work_keys_str_mv AT arnoldrw comparativeaaposvalidationofthebirefringentamblyopiascreenerwithisolatedsmallanglestrabismus
_version_ 1718395988215857152